Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases.
Charlotte SchubertInsa SchiffmannSaid C FarschtschiJean François EmileNicolaus KrögerPublished in: Neurology(R) neuroimmunology & neuroinflammation (2024)
This case report provides Class IV evidence. This is a single observational study without controls.